Predictive value of the serum homocysteine-to-albumin ratio for major adverse cardiovascular events after acute myocardial infarction: a retrospective cohort study
HAR is a strong and independent predictor of MACE in AMI patients. Given its simplicity, cost-effectiveness, and availability, HAR may serve as a valuable biomarker for cardiovascular risk stratification, especially in resource-limited settings. Further prospective studies are warranted to validate these findings and explore potential clinical applications.
Authors
- Meili Fu (ORCID: https://orcid.org/0009-0000-8176-3672)
- Ming Hu (ORCID: https://orcid.org/0000-0001-5513-2746)
- Runfeng Sun (ORCID: https://orcid.org/0009-0009-7908-0106)
- Jianying Zhou (ORCID: https://orcid.org/0000-0002-8924-935X)
- Zhenju Song (ORCID: https://orcid.org/0000-0001-9294-8824)
- Jiaping Wang (ORCID: https://orcid.org/0000-0001-9022-0231)
- H. T. Wu
- Na Wang
Institutions
- The First People’s Hospital of Lianyungang (CN)
Publication Details
- Journal
- Frontiers in Cardiovascular Medicine
- Published
- 2025-06-20
- DOI
- https://doi.org/10.3389/fcvm.2025.1574139
- Primary Topic
- Cardiac Imaging and Diagnostics
- Type
- article
- Field-Weighted Citation Impact
- 0.00